中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2015年
5期
623-629,630
,共8页
何国荣%穆鑫%李晓秀%王月华%方莲花%孙岚%吕扬%杜冠华
何國榮%穆鑫%李曉秀%王月華%方蓮花%孫嵐%呂颺%杜冠華
하국영%목흠%리효수%왕월화%방연화%손람%려양%두관화
百可利%帕金森病%6-羟多巴胺%黑质纹状体通路%内侧前脑束%纹状体尾壳核%神经保护
百可利%帕金森病%6-羥多巴胺%黑質紋狀體通路%內側前腦束%紋狀體尾殼覈%神經保護
백가리%파금삼병%6-간다파알%흑질문상체통로%내측전뇌속%문상체미각핵%신경보호
baicalein%Parkinson′s disease%6-hydroxydopamine%nigrostriatal pathway%medial fore-brain bundle%caudate putamen%neuroprotective
目的:观察百可利对6-羟多巴胺(6-OHDA)内侧前脑束(MFB)和纹状体尾壳核(CPu)两个不同注射位点帕金森病(PD)模型大鼠的治疗作用,两个注射位点模型分别记为:MFB-M,CPu-M。方法运用6-OHDA两点注射法,损毁大鼠左侧中脑多巴胺能神经元,制备PD模型。记录大鼠后肢肌电(EMG)信号频率观察肌肉震颤;测定大鼠自主活动;电化学法检测纹状体内多巴胺(DA)及其代谢产物含量;免疫组化法检测大鼠脑内酪氨酸羟化酶(TH)、OX-42表达;观察神经元超微结构变化。结果给药3周后,两个注射位点的模型组行为改变趋势一致,百可利在两个注射位点的模型动物上药效表现不同,在CPu-M组可明显提高PD大鼠自主活动数(P<0.05)。EMG信号分析显示,在MFB-M组,给予百可利,肌电频率降低55%;在CPu-M组,给予百可利,肌电频率降低60%。EMG时效研究表明,在 CPu-M组,百可利药效持续420 min以上。纹状体递质水平显示,两个注射位点的模型组DA递质水平差异很大,在CPu-M组,百可利能够明显升高DA水平(P<0.05)。两个注射位点的模型组免疫组织化学结果趋势一致,在CPu-M组,百可利有更明显神经元保护作用(P<0.05),在MFB-M组,百可利抑制小胶质细胞过度激活作用更强(P<0.01)。结论不同注射位点制备的PD模型能够反映不同时期PD的病理变化,百可利可通过抑制炎性介质生成和释放、保护残存神经元、恢复神经元功能等机制改善PD不同发病时期模型动物的行为学症状。
目的:觀察百可利對6-羥多巴胺(6-OHDA)內側前腦束(MFB)和紋狀體尾殼覈(CPu)兩箇不同註射位點帕金森病(PD)模型大鼠的治療作用,兩箇註射位點模型分彆記為:MFB-M,CPu-M。方法運用6-OHDA兩點註射法,損燬大鼠左側中腦多巴胺能神經元,製備PD模型。記錄大鼠後肢肌電(EMG)信號頻率觀察肌肉震顫;測定大鼠自主活動;電化學法檢測紋狀體內多巴胺(DA)及其代謝產物含量;免疫組化法檢測大鼠腦內酪氨痠羥化酶(TH)、OX-42錶達;觀察神經元超微結構變化。結果給藥3週後,兩箇註射位點的模型組行為改變趨勢一緻,百可利在兩箇註射位點的模型動物上藥效錶現不同,在CPu-M組可明顯提高PD大鼠自主活動數(P<0.05)。EMG信號分析顯示,在MFB-M組,給予百可利,肌電頻率降低55%;在CPu-M組,給予百可利,肌電頻率降低60%。EMG時效研究錶明,在 CPu-M組,百可利藥效持續420 min以上。紋狀體遞質水平顯示,兩箇註射位點的模型組DA遞質水平差異很大,在CPu-M組,百可利能夠明顯升高DA水平(P<0.05)。兩箇註射位點的模型組免疫組織化學結果趨勢一緻,在CPu-M組,百可利有更明顯神經元保護作用(P<0.05),在MFB-M組,百可利抑製小膠質細胞過度激活作用更彊(P<0.01)。結論不同註射位點製備的PD模型能夠反映不同時期PD的病理變化,百可利可通過抑製炎性介質生成和釋放、保護殘存神經元、恢複神經元功能等機製改善PD不同髮病時期模型動物的行為學癥狀。
목적:관찰백가리대6-간다파알(6-OHDA)내측전뇌속(MFB)화문상체미각핵(CPu)량개불동주사위점파금삼병(PD)모형대서적치료작용,량개주사위점모형분별기위:MFB-M,CPu-M。방법운용6-OHDA량점주사법,손훼대서좌측중뇌다파알능신경원,제비PD모형。기록대서후지기전(EMG)신호빈솔관찰기육진전;측정대서자주활동;전화학법검측문상체내다파알(DA)급기대사산물함량;면역조화법검측대서뇌내락안산간화매(TH)、OX-42표체;관찰신경원초미결구변화。결과급약3주후,량개주사위점적모형조행위개변추세일치,백가리재량개주사위점적모형동물상약효표현불동,재CPu-M조가명현제고PD대서자주활동수(P<0.05)。EMG신호분석현시,재MFB-M조,급여백가리,기전빈솔강저55%;재CPu-M조,급여백가리,기전빈솔강저60%。EMG시효연구표명,재 CPu-M조,백가리약효지속420 min이상。문상체체질수평현시,량개주사위점적모형조DA체질수평차이흔대,재CPu-M조,백가리능구명현승고DA수평(P<0.05)。량개주사위점적모형조면역조직화학결과추세일치,재CPu-M조,백가리유경명현신경원보호작용(P<0.05),재MFB-M조,백가리억제소효질세포과도격활작용경강(P<0.01)。결론불동주사위점제비적PD모형능구반영불동시기PD적병리변화,백가리가통과억제염성개질생성화석방、보호잔존신경원、회복신경원공능등궤제개선PD불동발병시기모형동물적행위학증상。
Aim To explore the therapeutical effect and mechanism of baicalein on two 6-hydroxydopamine (6-OHDA ) induced Parkinson′s disease (PD ) rat models,which received unilateral lesions of the left medial forebrain bundle (MFB ) or caudate putamen (CPu ) made by stereotaxic injection of 6-OHDA (MFB-M,CPu-M).Methods PD rat models were established by microinjection of 6-OHDA into MFB or CPu.The anti-tremor effect of baicalein on PD rat models was examined.Spontaneous activity was recor-ded. Dopamine (DA ), dihydroxyphenylacetic acid (DOPAC)and homovanilic acid (HVA)in striatum were quantified by HPLC-ECD.The tyrosine hydroxy-lase (TH)and OX-42 positive cells were detected by immunohistochemical method.The morphological vari-ation of the neurons was confirmed by analysis at an ul-trastructural level.Results Baicalein significantly in-creased the spontaneous activity in CPu-M.The elec-tromyography (EMG ) recordings revealed that com-pared with 6-OHDA group,the tremor frequency in ba-icalein group was decreased by 55% in MFB-M,and by 60% in CPu-M.6-OHDA treatment decreased DA levels in the striatum,while treatment with baicalein attenuated the DA decreases in CPu-M.Moreover,ba-icalein treatment could increase TH-positive neurons and decrease OX-42-postive microglia compared with 6-OHDA group in both MFB-M and CPu-M.Conclu-sions In the present study,it is illustrated that ①microinjection of 6-OHDA into the MFB and the CPu could cause different pathological changes of PD, which is important for efficacy evaluation;②baicalein showed the ability to alleviate the behavior symptoms in PD-rats at different stages by improving motor function and attenuating muscle tremor;③therapeutic effect of baicalein was produced by inhibiting the inflammatory medium production and release,anti-apoptosis,chan-ging dopamine catabolism, and inhibiting dopamine turnover.